Biosite hits Roche with patent litigation:
This article was originally published in Clinica
Executive Summary
San Diego, California-based Biosite has filed a complaint against Roche Diagnostics for allegedly infringing two of Biosite's patents related to methods of measuring cardiac troponin biomarkers. Roche and Biosite are already embroiled in a separate patent dispute initiated by the former in November (see Clinica No 1133, p 15). Roche's claims against Biosite refer to a device for separating and analysing plasma or serum from whole blood and to biosensing technology for use during the process.